AMPH - Amphastar Pharmaceuticals, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.97
|
Rev Est: $190.1M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$30.00
DETAILS
HIGH:
$30.00
LOW:
$30.00
MEDIAN:
$30.00
CONSENSUS:
$30.00
UPSIDE:
8.42%
Market Cap:
1.27B
Volume:
375,645
Avg Volume:
346,831
52 Week Range:
20.39-32.69
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
0.88
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
2,028
IPO Date:
2014-06-25
EPS (TTM):
3.29
P/E Ratio:
11.27
Revenue (TTM):
731.97M
Total Assets:
1.58B
Total Debt:
650.55M
Cash & Equiv:
151.61M
Rev Growth (5Y):
17.8%
EPS Growth (5Y):
25.9%
FCF Growth (5Y):
283.6%
ROCE:
15.7%
Debt/Equity:
0.89
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $0.93 | $0.77 | +20.8% | $191.8M | $190.5M | +0.7% |
| 2025-08-07 | $0.85 | $0.71 | +19.7% | $174.4M | $177.1M | -1.5% |
| 2025-05-07 | $0.74 | $0.66 | +12.1% | $170.5M | $173.1M | -1.5% |
| 2025-02-27 | $0.92 | $1.01 | -8.9% | $186.5M | $188.8M | -1.2% |
| 2024-11-06 | $0.96 | $0.99 | -3.0% | $188.8M | $192.1M | -1.7% |
| 2024-08-07 | $0.94 | $0.77 | +22.1% | $182.4M | $170.9M | +6.7% |
| 2024-05-08 | $1.04 | $0.96 | +8.3% | $171.8M | $174.7M | -1.6% |
| 2024-02-28 | $0.88 | $0.93 | -5.4% | $178.1M | $175.7M | +1.4% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 731.97M | 644.39M | 498.99M | 437.77M | 349.85M | 322.36M | 294.67M | 240.18M | 255.16M | 251.52M | 210.46M | 229.68M |
| Net Income | 159.52M | 137.54M | 91.39M | 62.12M | 1.40M | 48.94M | (5.74M) | 4.51M | 10.53M | (2.79M) | (10.70M) | 11.86M |
| EPS | 3.29 | 2.85 | 1.88 | 1.30 | 0.03 | 1.04 | -0.12 | 0.10 | 0.23 | -0.06 | -0.25 | 1.48 |
| Total Assets | 1.58B | 1.51B | 741.99M | 671.53M | 631.24M | 586.97M | 513.56M | 454.67M | 427.74M | 390.14M | 389.37M | 338.75M |
| Total Debt | 650.55M | 623.64M | 102.58M | 104.66M | 67.27M | 66.62M | 50.21M | 47.16M | 37.72M | 41.10M | 43.70M | 32.17M |
| Cash & Equivalents | 151.61M | 144.30M | 156.10M | 126.35M | 92.64M | 75.55M | 86.34M | 65.59M | 72.35M | 66.07M | 67.83M | 53.59M |
| Operating Cash Flow | 213.39M | 183.50M | 89.18M | 97.99M | 57.27M | 41.76M | 38.19M | 39.21M | 38.56M | 10.68M | 21.05M | 31.04M |
| Free Cash Flow | 172.34M | 145.34M | 65.15M | 70.54M | 23.41M | 207,000 | (8.62M) | 4.11M | 17.18M | (5.37M) | 553,000 | 12.74M |
| FCF per Share | 3.56 | 3.01 | 1.34 | 1.48 | 0.50 | 0.00 | -0.19 | 0.09 | 0.38 | -0.12 | 0.01 | 1.59 |
| Book Value | 732.30M | 639.42M | 528.66M | 445.52M | 402.31M | 381.37M | 332.44M | 337.33M | 329.25M | 295.51M | 281.86M | 251.54M |
| Cash & ST Investments | 221.65M | 256.81M | 175.76M | 136.67M | 105.62M | 89.52M | 89.17M | 68.23M | 72.88M | 66.07M | 67.83M | 53.59M |
| ROC Equity | 0.22 | 0.22 | 0.17 | 0.14 | 0.00 | 0.13 | -0.02 | 0.01 | 0.03 | -0.01 | -0.04 | 0.05 |